Skip to main content
. 2023 Mar 22;183(6):520–531. doi: 10.1001/jamainternmed.2023.0456

Figure 2. Net Clinical Outcome of SD-PA, HD-PA, and TA Through day 28 Among the 3 Study Groups.

Figure 2.

A, Cumulative net clinical outcome curves, including any composite thrombotic event, major bleeding, and all-cause death. B, Cumulative mortality curves. C, Cumulative thrombosis curves. D, Cumulative major bleeding curves. P-values shown in the graphs are for global comparison of cumulative incidence curves using Gray test. HD-PA refers to high-dose prophylactic anticoagulation; SD-PA, standard-dose prophylactic anticoagulation; and TA therapeutic anticoagulation.

aP = .01 for comparison of HD-PA vs SD-PA.

bP < .001 for comparison of HD-PA vs SD-PA.

cP < .001 for comparison of TA vs SD-PA.